Katsuya Toshida

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications

Spatiotemporal dynamics of the tumor microenvironment in hepatocellular carcinoma during combination immunotherapy.

Spatiotemporal dynamics of the tumor microenvironment in hepatocellular carcinoma during combination immunotherapy.

Journal: Hepatology communications
Published: February 23, 2026

ASO Visual Abstract: Cyclic GMP-AMP Synthase Expression in Hepatocellular Carcinoma: A Double-Edged Biomarker for Prognosis and Immunotherapy Response.

ASO Visual Abstract: Cyclic GMP-AMP Synthase Expression in Hepatocellular Carcinoma: A Double-Edged Biomarker for Prognosis and Immunotherapy Response.

Journal: Annals of surgical oncology
Published: February 19, 2026

Correction: Cyclic GMP-AMP Synthase Expression in Hepatocellular Carcinoma: A Double-Edged Biomarker for Prognosis and Immunotherapy Response.

Correction: Cyclic GMP-AMP Synthase Expression in Hepatocellular Carcinoma: A Double-Edged Biomarker for Prognosis and Immunotherapy Response.

Journal: Annals of surgical oncology
Published: January 31, 2026

Can machine learning predict vessels that encapsulates tumor cluster ptterns and histological differentiation in solitary small (< 5 cm) hepatocellular carcinoma?

Can machine learning predict vessels that encapsulates tumor cluster ptterns and histological differentiation in solitary small (< 5 cm) hepatocellular carcinoma?

Journal: Surgery today
Published: January 28, 2026

Cyclic GMP-AMP Synthase Expression in Hepatocellular Carcinoma: A Double-Edged Biomarker for Prognosis and Immunotherapy Response.

Cyclic GMP-AMP Synthase Expression in Hepatocellular Carcinoma: A Double-Edged Biomarker for Prognosis and Immunotherapy Response.

Journal: Annals of surgical oncology
Published: November 21, 2025

PNPLA3 I148M Variant Activates Hepatic Stellate Cells via AMIGO2 Upregulation Using iPSC-Derived Model.

PNPLA3 I148M Variant Activates Hepatic Stellate Cells via AMIGO2 Upregulation Using iPSC-Derived Model.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: October 27, 2025

Patatin-Like Phospholipase Domain Containing 3 I148M Variant Affects Hepatocellular Carcinoma Recurrence After Liver Resection.

Patatin-Like Phospholipase Domain Containing 3 I148M Variant Affects Hepatocellular Carcinoma Recurrence After Liver Resection.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: July 08, 2025

ASO Author Reflections: Prognostic Significance of Tumor-Cell-Derived SIRPα in Intrahepatic Cholangiocarcinoma.

ASO Author Reflections: Prognostic Significance of Tumor-Cell-Derived SIRPα in Intrahepatic Cholangiocarcinoma.

Journal: Annals of surgical oncology
Published: June 27, 2025

The Metazoan SpoT Homolog 1 promotes ferroptosis by regulating the intracellular redox cycle and iron levels in hepatocellular carcinoma.

The Metazoan SpoT Homolog 1 promotes ferroptosis by regulating the intracellular redox cycle and iron levels in hepatocellular carcinoma.

Journal: International journal of clinical oncology
Published: March 24, 2025

Expression of Signal Regulatory Protein Alpha in Tumor Cells is the Key Factor in Intrahepatic Cholangiocarcinoma.

Expression of Signal Regulatory Protein Alpha in Tumor Cells is the Key Factor in Intrahepatic Cholangiocarcinoma.

Journal: Annals of surgical oncology
Published: January 08, 2025

Induced pluripotent stem cell-derived stellate cells promote proliferation of induced pluripotent stem cell-derived hepatocytes through the mitogen-activated protein kinase pathway via hepatocyte growth factor.

Induced pluripotent stem cell-derived stellate cells promote proliferation of induced pluripotent stem cell-derived hepatocytes through the mitogen-activated protein kinase pathway via hepatocyte growth factor.

Journal: Surgery today
Published: November 19, 2024

Outcome of hepatectomy after systemic therapy for hepatocellular carcinoma: a Japanese multicenter study.

Outcome of hepatectomy after systemic therapy for hepatocellular carcinoma: a Japanese multicenter study.

Journal: Surgery today
Published: June 30, 2024
Showing 1-12 of 60

Last Updated: 09/26/2026